MedTrace Logo

Swecrit Biobank - Blood Samples From Critically Ill Patients and Healthy Controls

NCT04974775 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 8500

Last updated 2025-05-29

No results posted yet for this study

Summary

Blood samples are collected and stored in a biobank for later analysis of circulating substances in peripheral blood and genetic variations in patients with severe critical illness and risk of death. The aim is to analyze stored samples in order to identify substances that can help predict the outcome of critically ill patients, but also to optimize treatment and possibly prevent serious illness and death in the future.

Conditions

Interventions

DIAGNOSTIC_TEST

Blood collection

Sampling on admission to ICU (all patients)

DIAGNOSTIC_TEST

Blood collection, serial sampling

Additional sampling to admission samples in 1. the Cardiac Arrest group after 12 and 48 hours 2. the Covid-19 group on day 2 and 7 while in the ICU 3. the Covid-19 group after 3 and 12 months.

Sponsors & Collaborators

  • Region Skane

    collaborator OTHER

  • Lund University

    collaborator OTHER

  • Skane University Hospital

    lead OTHER

Principal Investigators

  • Hans Friberg, MD, PhD · Skane University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2021-12-31
Completion
2026-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04974775 on ClinicalTrials.gov